Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The diaphragm-sparing effect of interscalene block with a low-volume of ropivacaine 0.1% vs. 0.5%: A double-blind, controlled, randomised trial.

European journal of anaesthesiology and intensive care·2026

Same author

Epidemiology from 1988 to 2020 of domestic and drug poisonings: analysis of the CIGUE database of Lille Poison Control Centre.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026

Same author

BibliZap: An exploratory evaluation of an automated multi-level citation searching tool for systematic and rapid reviews.

Research synthesis methods·2026

Same author

Spatial clustering of out-of-hospital cardiac arrest in northern France and its association with social deprivation: a population-based registry study.

Emergency medicine journal : EMJ·2026

Same author

Congrès EMOIS, Saint-Malo, 10-13 mars 2026.

Journal of epidemiology and population health·2026

Same author

Artificial Intelligence Models for Predicting Triage in Emergency Departments: Seven-Month Retrospective Comparative Study of Natural Language Processing, Large Language Model, and Joint Embedding Predictive Architectures.

JMIR medical informatics·2026

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Detection of adverse drug events detection: data aggregation and data mining.

Emmanuel Chazard¹, Grégoire Ficheur, Béatrice Merlin

¹Lille university hospital, EA2694, Lille, France. emmanuel@chazard.org

Studies in Health Technology and Informatics

|September 12, 2009

Summary

This study used data mining on electronic health records to automatically identify adverse drug events (ADEs) and create alert rules. Researchers developed a method to detect ADEs and prevent them, validating 75 rules from 10,500 hospitalizations.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Related Experiment Videos

Last Updated: Jun 20, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

Health Informatics
Pharmacovigilance
Clinical Data Mining

Background:

Adverse drug events (ADEs) represent a significant public health concern.
Electronic health records (EHRs) contain vast amounts of data that can be leveraged for ADE detection.
Proactive identification and prevention of ADEs are crucial for patient safety.

Purpose of the Study:

To develop an automated method for identifying ADEs from EHRs.
To generate actionable alert rules for preventing identified ADEs.
To validate the efficacy of the data mining approach in a real-world setting.

Main Methods:

Data transformation of complex EHR data into binary cause-and-effect variables.
Application of statistical methods to identify cause-to-effect relationships.
Utilizing decision trees for rule discovery, exemplified with vitamin K antagonists.

Main Results:

Successfully mined 10,500 hospitalizations from Danish and French cohorts.
Automatically generated 250 potential ADE-related rules.
Validated 75 of the generated rules, demonstrating the method's potential.

Conclusions:

Automated data mining of EHRs is a viable approach for identifying ADEs.
The developed method can generate validated rules to aid in ADE prevention.
Further research can expand rule discovery across various drug classes and patient populations.